AbbVie and Argenx collaborate to develop ARGX-115
21 April 2016 | By Victoria White, Digital Content Producer
ARGX-115 targets the novel immuno-oncology target GARP, a protein believed to contribute to immunosuppressive effects of T-cells...
List view / Grid view
21 April 2016 | By Victoria White, Digital Content Producer
ARGX-115 targets the novel immuno-oncology target GARP, a protein believed to contribute to immunosuppressive effects of T-cells...
20 April 2016 | By Victoria White, Digital Content Producer
Emergent BioSolutions' ES425 molecule is being developed as a potential therapeutic for triple-negative breast cancer (TNBC)...
20 April 2016 | By Victoria White, Digital Content Producer
Enterome Bioscience has raised €14.5 million in a Series C financing round that it will use to advance the development of its lead drug candidate EB 8018...
19 April 2016 | By Victoria White, Digital Content Producer
Evidence is mounting that even mild chronic cold stress in lab mice is skewing results in studies of cancer, inflammation, and more...
19 April 2016 | By Victoria White, Digital Content Producer
Johnson Matthey and Domainex have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services...
19 April 2016 | By Victoria White, Digital Content Producer
Results of a new study could help researchers develop more effective combination therapies and breathe new life into forgotten pancreatic cancer drugs...
19 April 2016 | By Victoria White, Digital Content Producer
New preclinical data show the combination of lenvatinib and everolimus yield greater antitumour activity than either agent alone in kidney cancer...
19 April 2016 | By Victoria White, Digital Content Producer
Enterome has signed a license agreement with Vertex to research, develop and commercialise novel small molecule FimH antagonists...
18 April 2016 | By Victoria White, Digital Content Producer
A biodegradable nanoparticle, developed by researchers at Northwestern Medicine, offers an innovative way to halt asthma...
18 April 2016 | By Victoria White, Digital Content Producer
IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma)...
18 April 2016 | By Victoria White, Digital Content Producer
SEL24 is a dual inhibitor of PIM and FLT3 kinases. It is the first molecule with this mechanism of action to progress to such stage of development...
18 April 2016 | By Victoria White, Digital Content Producer
Heptares and Kymab are to colllaborate to discover, develop and commercialise novel antibody therapeutics targeting a number of GPCRs...
15 April 2016 | By Victoria White, Digital Content Producer
An analysis comparing the differences between over 40 strains of Zika virus identified significant changes in both amino acid and nucleotide sequences...
15 April 2016 | By Victoria White, Digital Content Producer
Researchers from MIT and MGH have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumours...
15 April 2016 | By Victoria White, Digital Content Producer
A study suggests that stimulating heat production in brown adipose tissue can improve weight-management and glucose tolerance...